Calcigen

Quick links to important sections

Calcigen

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calcigen

Calcigen is an oral combination medicine or nutritional supplement that provides a foundational supply of two essential micronutrients: the mineral nutrient Calcium and Colecalciferol (Vitamin D3). It is fundamentally classified within the high-level therapeutic category of Vitamins Minerals Nutrients.

Property Description
Active ingredient Calcium (Elemental) and Colecalciferol (Vitamin D3)
Form Oral Solid (Tablet, Capsule) or Oral Liquid (Solution)
Pharmacological class Mineral Nutrient and Vitamin D Analog
Common use Supplementation to support bone health and mineral balance
Origin Combination of an essential mineral and a fat-soluble vitamin derivative

Defining Calcigen: Type, Form, and Origin

Calcigen is classified as a combination product, merging an essential mineral with a prohormone to create a functional nutritional supplement. It is administered via the oral route and is commonly supplied as various solid dosage forms, including tablets and capsules. The Colecalciferol component is a fat-soluble vitamin derivative that the body must convert into its active hormonal form. This distinction is clinically recognized, as Colecalciferol is placed in a class of medications called Vitamin D analogs. This classification simply means it's a compound structurally related to Vitamin D that the body uses to regulate calcium and phosphorus.


Core Composition: The Synergy of Calcium and Colecalciferol

The core composition of Calcigen features the two active ingredients, Elemental Calcium and Colecalciferol, whose actions are mutually dependent for optimal efficacy. This synergy is essential because, while Calcium is the necessary structural component for bone health, the Colecalciferol (Vitamin D3) functions as a Vitamin D Analog required to significantly boost the small intestine's ability to absorb the Calcium element.

This pairing is intended for addressing states of combined nutritional insufficiency. Calcium and Vitamin D combination products are utilized for the correction of calcium and Vitamin D deficiency and as an adjunct to therapy for promoting bone health in at-risk patient groups, such as the elderly. This indicates the combination is a recognized tool for addressing combined nutritional gaps.


General Purpose and Function

The general purpose of Calcigen is to support the body’s overall calcium homeostasis and promote effective bone mineralization. By ensuring that the body can efficiently absorb and utilize the Calcium component, the preparation helps sustain the proper mineral balance in the body, which is critical not only for maintaining skeletal health and density but also for the proper functioning of muscles and nerves. A typical use scenario involves long-term supplementation for adults or elderly individuals requiring continuous mineral nutritional support to maintain the structural integrity of the skeleton.

Regulatory References

  1. MedlinePlus, Vitamin D Analogs

What side effects are possible with Calcigen?

Possible Side Effects and Safety Information

The safety profile of Calcigen is dependent on its specific formulation (e.g., calcium/vitamin D versus calcitonin-salmon products).

Adverse Reaction Scope

Common Adverse Reactions: The most frequently reported adverse effects for formulations containing calcium and vitamin D are gastrointestinal, including constipation, nausea, and stomach upset. For calcitonin-salmon products, common side effects include rhinitis (nasal irritation, dryness, crusting, or bleeding) with the nasal spray, flushing (warmth/redness of the face or hands), and injection site reactions with injectable forms.

Serious Adverse Reactions:

  • Malignancy Risk: Regulatory reviews (e.g., FDA, EMA) have identified a potential increased risk of overall malignancies with the long-term use of calcitonin-salmon, with treatment being limited in some jurisdictions.
  • Severe Hypersensitivity: Allergic reactions, including anaphylactic shock (which can be fatal), are a risk, particularly with calcitonin-salmon, necessitating caution and potential skin testing prior to use.
  • Hypercalcemia: Overuse or high doses of calcium/vitamin D formulations can lead to hypercalcemia (high blood calcium levels), which may cause symptoms like increased thirst, confusion, vomiting, and kidney issues.

Safety Restrictions and Contraindications

Calcigen is generally contraindicated in patients with pre-existing hypercalcemia, hypervitaminosis D, or severe kidney impairment (including kidney stones). The long-term use of calcitonin-salmon for conditions such as osteoporosis is restricted to the shortest effective duration due to the malignancy risk. Close monitoring of serum calcium levels and nasal mucosa is recommended during treatment with certain formulations.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving Calcigen (Calcium and Colecalciferol) results primarily in hypercalcaemia (elevated serum calcium) due to hypervitaminosis D. Regulator-documented manifestations are broad, affecting multiple body systems. Early symptoms often include gastrointestinal effects such as nausea, vomiting, anorexia, constipation, and abdominal pain, alongside systemic signs like weakness, apathy, polyuria, and excessive thirst (polydipsia).

Severe and persistent hypercalcaemia constitutes a life-threatening emergency that may escalate to serious neurological effects, including mental disturbances, confusion, and ultimately coma and death. Overdosage is documented as capable of causing severe complications, including irreversible renal damage, nephrocalcinosis, kidney stones, and cardiac arrhythmias.

Due to the high risk of persistent, life-threatening hypercalcaemia, regulatory bodies mandate that immediate medical attention must be sought upon suspicion of overdose. Treatment is essentially symptomatic and supportive. The immediate procedural step required is the discontinuation of the Calcigen preparation and all other calcium and Vitamin D sources. Patients taking cardiac glycosides require careful monitoring, as do pregnant patients, where prolonged hypercalcaemia must be avoided due to the risk of adverse effects on the developing foetus.

Therapeutic Uses of Calcigen

The core function of Calcigen is to provide essential nutritional support for the body’s mineral balance and skeletal integrity, generally applied across domains where systemic imbalance leads to symptoms related to physical discomfort. This combination is commonly used in deficiency states and as an adjunct to specific osteoporosis treatments.

Calcigen is commonly used to help with treating and preventing states of Vitamin D deficiency and Calcium deficiency, including conditions such as osteomalacia and rickets. This supportive use assists the patient during difficult episodes by contributing to a necessary mineral reserve. It is considered relevant for the supportive management of osteoporosis, a condition characterized by skeletal fragility and chronic low bone mass.

A key therapeutic benefit is the support for bone mineral density, which may assist with reducing the potential for fractures. This contributes to easing the overall symptom load for patient groups such as older adults and postmenopausal women, and those with malabsorption.


Quick Fact: Relief for Skeletal Fragility

Eligibility and Restrictions for Use

This section outlines the official population eligibility and non-eligibility rules for this medicine (a combination of Calcium Carbonate and Cholecalciferol, or Vitamin D3), as established in governmental regulatory documents.

Eligibility Scope

Classification Official Regulatory Status
Populations for Whom Use is Allowed Individuals with documented Calcium and Vitamin D deficiency and those receiving specific osteoporosis treatment who are at risk of deficiency.
Populations for Whom Use is Contraindicated Patients with Hypercalcaemia (high blood calcium levels), Hypercalciuria (high urine calcium), Hypervitaminosis D (high Vitamin D levels), Severe Renal Impairment, or a history of Nephrolithiasis (kidney stones) or Nephrocalcinosis.
Age-Related Rules Use is not recommended for children under 12 years (for certain high-dose formulations) or adolescents under 18 years, typically due to lack of established safety data.
Conditional Use Populations Patients with Sarcoidosis or Mild to Moderate Renal Impairment must use the medicine only with close medical supervision and regular monitoring of calcium levels.

Eligibility Classification

The medicine's eligibility is determined by its potential to affect mineral balance. Absolute contraindications prohibit use when pre-existing high levels of calcium or Vitamin D are present, or when the kidneys' ability to manage mineral excretion is severely compromised. Use is restricted or conditional for other groups, like those with moderate kidney issues or sarcoidosis, where the risk of mineral imbalance requires stringent medical monitoring.

What should I know about interactions with other medicines?

Calcigen Interactions with other medicines and products

Calcigen (calcium) products may interact with a range of medicinal products, primarily by reducing the absorption of co-administered oral medicines or through physical incompatibility in intravenous (IV) solutions.

Product Category Interacting Medicine Examples Official Constraint
Antibiotics Tetracyclines (e.g., Doxycycline), Fluoroquinolones (e.g., Ciprofloxacin) Reduced oral absorption; administration must be separated by several hours.
Thyroid Hormones Levothyroxine Reduced oral absorption; administration must be separated, typically by at least four hours.
Bisphosphonates Alendronate, Risedronate Reduced oral absorption; administration must be separated by a specified time interval.
IV Antibiotics Ceftriaxone Contraindicated for simultaneous IV co-administration in all patients due to precipitation risk.

Oral Administration Constraints: The primary mechanism for oral interactions involves chelation or binding in the gut, which significantly reduces the absorption and subsequent plasma concentration of the interacting medicine. This effect necessitates specific timing requirements, such as taking the interacting oral medicine (including iron and zinc supplements) several hours before or after the calcium product, to ensure its full therapeutic effect is achieved.

Intravenous Restrictions: The official regulatory documents strictly contraindicate the mixing or simultaneous co-infusion of IV calcium solutions and Ceftriaxone, even through separate lines in the same site, due to the documented risk of precipitation of ceftriaxone-calcium salt. In infants aged 28 days or less, the risk is severe enough that the use of Ceftriaxone is contraindicated if they are receiving or are expected to receive IV calcium-containing solutions.

Mechanism of Action

The mechanism of action for Calcigen involves a targeted approach to modulating the activity of dysregulated physiological processes. The drug's action relies on interaction with key regulatory systems at the molecular level.

Calcigen initiates its effect by acting within domains involving receptor- or enzyme-mediated signaling. It selectively engages defined biological targets to modify their activity. This primary interaction is crucial as it reduces the intensity of specific signaling events at the cellular level.

Following initial binding, the compound influences the signaling dynamics in defined neural or humoral pathways. Calcigen modifies pathway activity that may escalate under certain conditions, influencing the regulation of processes driven by distinct signaling patterns. This results in a reduction of overactive physiological responses.

Calcigen further engages mechanisms that influence feedback regulation within pathways, often initiating or suppressing signaling sequences that lead to downstream effects. By modifying these early molecular steps, the mechanism alters mediator activity. This adjustment of regulatory systems results in a modification of the downstream signaling consequences of the affected pathway.

Dosage and Administration Information

How to Use Calcigen — Administration Instructions

This medicine is taken by the oral route (by mouth) and must be administered strictly according to the dosing regimen to ensure proper use.

Dosage and Frequency

The specific dose and frequency are determined by the medication’s strength and dosage form (capsule, solution, or wafer) and the patient's age. The following are typical instructions:

Dosage Form Age Group Typical Dosing Schedule
Capsule (e.g., 5000 IU) Adults One capsule once a day.
Oral Solution (e.g., 1000 IU/drop) Adults One drop once or twice a day.
Oral Solution (e.g., 400 IU/drop) Infants & Children One drop once a day.
Wafer (e.g., 14,000 IU) Children 6 years and older One wafer once a week for 6 weeks.

Administration Technique

  • Chewable Wafer: Must be thoroughly chewed or crushed before swallowing; do not swallow the wafer whole.
  • Oral Solution: Use the specific dropper provided with the product to measure the exact dose. The liquid may be dropped directly into the mouth or mixed with food or other liquids, such as water or juice. For infants under two years, place a drop on a pacifier or nipple and allow the baby to suck for at least 30 seconds.

Missed Dose Instructions

If a dose is missed, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose entirely and return to your regular dosing schedule. Do not double doses to make up for a missed one.

Recent Clinical Evidence

Calcigen: Recent Clinical Evidence

Evidence for Correction of Calcium and Vitamin D Deficiency

The combination of calcium and vitamin D (Colecalciferol) was studied for its role in addressing states of confirmed nutritional insufficiency. Research explored this aspect primarily in short-term Randomized Controlled Trials (RCTs) and observational studies involving adults and elderly individuals who presented with measured deficits. Studies consistently reported measurable shifts in blood markers, such as 25-hydroxyvitamin D, during the observation period. This evidence contributes to the evidence base when underlying nutritional gaps are identified. However, there is limited information that tracks these patients over the long term to examine how the correction of these short-term nutritional markers relates to observations of extended skeletal health.

Evidence Supporting Skeletal Health in High-Risk Adults

The use of this combination as supportive therapy for conditions characterized by skeletal fragility was evaluated in large-scale RCTs and subsequent Systematic Reviews. Research explored the effect on major skeletal outcomes, primarily measuring the incidence of fractures and monitoring changes in Bone Mineral Density (BMD). Findings were often mixed and varied across studies, particularly regarding fracture incidence. Regulatory summaries highlight that these patterns are influenced by significant heterogeneity in research designs, including the differences in the amounts of calcium and vitamin D utilized across trials.

Key Areas of Scientific Uncertainty

Scientific evaluations of Calcigen point to several areas where certainty remains low or research is still developing. A key area of uncertainty is the primary prevention of fractures in the general adult population: large trials focusing on this broad group of people without confirmed deficiency or osteoporosis often reported an absence of a clear, consistent pattern. The evidence is varied across studies due to the wide range of doses and formulations tested. Additionally, comparative evidence is lacking for certain patient subgroups.

Key Studies & References

  1. Rickets and osteomalacia - NHS Guidance on symptoms, diagnosis and treatment
  2. Vitamin D Deficiency: Evaluation and Treatment - Nationwide Children's Hospital Guidance (Addressing deficiency syndromes)

Frequently Asked Questions (FAQ)

Common questions about Calcigen (FAQ)


Q: What is the difference between Calcigen and a regular supplement?

Official documentation describes Calcigen as a combination of Calcium (a mineral nutrient) and Colecalciferol (Vitamin D3, a vitamin D analog). The combination is an officially recognized therapeutic approach for addressing states of combined nutritional insufficiency of both components.


Q: Are there different forms of Calcigen available (e.g., tablet, liquid)?

Regulatory labeling indicates that Calcigen is authorized for administration via the oral route in several different dosage forms. These commonly include oral solid forms such as tablets, capsules, or chewable wafers, as well as oral liquid solutions.


Q: How long can a person usually take Calcigen for?

Studies and official information indicate that use for the correction of deficiency or as supportive therapy may be long-term. Use for this duration is typically supported by and necessitates periodic medical review and monitoring of blood calcium and vitamin D levels.


Q: Does Calcigen interact with common vitamins or herbal supplements?

Official product labeling requires that the administration of Calcigen and other mineral supplements, specifically including iron or zinc, be separated by several hours. This separation is necessary to prevent a reduction in their absorption in the gut.


Q: Can Calcigen be used by people who have kidney issues?

Calcigen is officially contraindicated for use in individuals with severe renal impairment (severe kidney issues) or certain related conditions. Official information indicates use is restricted to individuals with mild to moderate kidney impairment, requiring close medical supervision and regular monitoring.


Q: Has Calcigen been studied for use in children or adolescents?

Regulatory documents list specific dosing schedules for infants and children when Calcigen is used under medical guidance. However, the use of certain high-dose formulations may be officially not recommended for children under a specified age due to a lack of established safety data.


Q: Why do some people say Calcigen didn't work for them?

Official summaries of clinical research highlight that findings on major skeletal outcomes, such as fracture incidence, have been mixed and varied across studies, particularly in the general population. This scientific variability may account for differences in patient experience.


Q: Does Calcigen have any effects on metabolism?

The official mechanism of action is centered on the maintenance of calcium homeostasis (keeping mineral levels stable) and mineral balance in the body. This function is achieved by regulating processes that influence the body’s absorption and utilization of calcium.


Q: If I have allergies, can I still take Calcigen?

According to official product information, Calcigen is contraindicated in patients with a known hypersensitivity (allergic reaction) to the active substances or to any of the other inactive components (excipients) used in the product’s formulation.


Q: What are the signs of an allergic reaction to Calcigen?

The official safety information warns of the risk of severe hypersensitivity reactions. The signs of such an allergic reaction may include swelling of the face, lips, tongue, or throat, and difficulty breathing.


Q: Is Calcigen affected by sun exposure or temperature?

Official storage instructions require the medicine to be kept in its original packaging and to be protected from light and moisture. It must also be stored below a specified temperature to maintain the stability of the active ingredients.


Q: Do you need a prescription to get Calcigen?

The legal status of Calcigen is defined in regulatory documents and varies by region. Official labeling in your jurisdiction will state whether the product is authorized as a prescription medicine or is available over-the-counter (non-prescription).


Q: How quickly does Calcigen typically start to work?

Clinical studies have shown that the product’s use is associated with measurable shifts in blood markers related to mineral balance during the observation period. The full clinical effect, however, may take longer to become established.


Q: If I stop taking Calcigen, will the effects immediately go away?

Regulatory data indicate that the product's components are gradually processed and eliminated from the body. Because of this, the effects will gradually diminish over time rather than stopping immediately.


Q: Is Calcigen known to cause drowsiness or affect driving?

Official regulatory information typically states whether the medicine has no influence or a minor influence on the ability to drive and use machines. Official labeling generally states that the medicine is not expected to influence the ability to drive.


Q: Can Calcigen make you feel tired or fatigued?

Regulatory documents list common and uncommon adverse effects, which may include general symptoms such as fatigue. This symptom may also be noted in cases of serious adverse effects, such as hypercalcemia (high blood calcium levels).


Q: What are the less common side effects of Calcigen?

The full list of adverse effects in regulatory documentation includes effects categorized by frequency. This means official sources list side effects considered uncommon (affecting up to 1 in 100 people) and rare (affecting up to 1 in 1,000 people).


Q: Does Calcigen cause any known changes in mood or behavior?

Official labeling may list psychiatric disorders as a possible adverse effect. Changes in mood or behavior, such as confusion, have been noted as potential symptoms of the serious adverse effect, hypercalcemia.


Q: Is it normal to feel a change in appetite while using Calcigen?

Regulatory documents list a decrease in appetite as a possible adverse reaction. Changes in appetite, along with nausea and vomiting, can occur and may be noted as signs of high blood calcium levels (hypercalcemia).


Q: Can Calcigen affect the results of common lab tests?

Official documentation includes a precaution that the product may lead to elevated calcium levels in the blood. This high level can potentially affect the accuracy of laboratory tests designed to measure calcium concentration.


Q: What types of over-the-counter pain relievers interact with Calcigen?

Regulatory documents state that any medication containing calcium should be used cautiously with other products that may affect mineral levels. The drug may affect the absorption of other oral medicines, which may necessitate careful timing between doses.


Q: Are there foods or drinks that should be avoided when taking Calcigen?

Official product information may recommend avoiding foods high in certain acids, such as oxalic acid (found in foods like spinach and rhubarb) or phytic acid (found in whole cereals). These substances have been noted to reduce calcium absorption when consumed close to the time of administration.


Q: Is it safe to take Calcigen with blood pressure medicine?

Regulatory documents describe an interaction with certain types of blood pressure medicine, specifically thiazide diuretics. Official information indicates that this combination is used only with caution and close medical monitoring due to the potential for excessive calcium levels in the blood.


Q: How does Calcigen interact with commonly prescribed diabetes drugs?

Regulatory information indicates that the product's effect on mineral balance (calcium and phosphorus) must be considered. Changes to these mineral levels can affect overall physiological function and potentially alter the effects of other systemic medications.


Q: What is the official guidance on using Calcigen during pregnancy?

Official guidance states that use during pregnancy is allowed only if a documented deficiency exists, as the vitamin D component is necessary for fetal development. Doses are recommended to be strictly controlled, as official guidance advises against excessive Vitamin D intake.


Q: Is Calcigen safe for use while breastfeeding?

The active components are known to be excreted into human milk. While generally acceptable at therapeutic doses, regulatory guidance notes that monitoring of the infant's calcium levels may be considered necessary if the mother is receiving high doses of the product.


Q: Is Calcigen known to affect fertility in men or women?

The regulatory documents include a statement on the potential for effects on fertility. Available data indicate that the product has no established adverse effect on male or female fertility.


Q: What are the inactive ingredients in Calcigen?

The official product labeling provides a complete list of all inactive ingredients (excipients) in the medicine. These components are included to ensure the stability, physical form, and proper administration of the product.


Q: What is the risk of dependence or addiction related to Calcigen?

Official regulatory documents typically confirm that there is no known risk of drug dependence, tolerance, or abuse associated with the use of the product.


Q: Are there specific instructions for stopping Calcigen use?

Regulatory guidance on discontinuation typically indicates that for nutritional supplementation, no specific tapering or stopping instructions are usually necessary. The need for ongoing use is typically reviewed during scheduled medical consultations.

How should Calcigen be stored and disposed of?

Official Storage and Disposal Requirements

Calcigen (Calcium and Colecalciferol) must be stored strictly according to the conditions defined in official regulatory labeling to maintain the stability of the vitamin D component.

Requirement Area Labeled Instructions
Temperature & Protection Store below 25 C or 30 C. Protect from light and moisture. Do not freeze.
Container & Access Keep in the original container or outer carton. Keep this medicine out of the sight and reach of children.
Disposal Do not throw away unused or expired medicine via household waste or wastewater. Consult a pharmacist for proper disposal methods guided by local regulations.

These official statements ensure product quality until the expiration date and mandate safe, environmentally compliant handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calcigen found in:

A-Z Index: